| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 55545 |
| 1 | ADALIMUMAB | 44092 |
| 2 | METHOTREXATE SODIUM | 13278 |
| 3 | METHOTREXATE | 13207 |
| 4 | EVOLOCUMAB | 7256 |
| 5 | EXENATIDE | 6202 |
| 6 | INTERFERON BETA-1A | 6066 |
| 7 | DULAGLUTIDE | 6026 |
| 8 | PREDNISONE | 5674 |
| 9 | FOLIC ACID | 5598 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INSULIN LISPRO-AABC | 105 | 0.1927 |
| 1 | CABOTEGRAVIR AND RILPIVIRINE | 64 | 0.1910 |
| 2 | GALCANEZUMAB-GNLM | 3211 | 0.1884 |
| 3 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 18 | 0.1818 |
| 4 | IOFLUPANE I-123 | 50 | 0.1520 |
| 5 | 68GA-DOTATATE | 19 | 0.1462 |
| 6 | CABOTEGRAVIR | 65 | 0.1308 |
| 7 | HYDROXYPROGESTERONE CAPROATE | 2435 | 0.1182 |
| 8 | IXEKIZUMAB | 2263 | 0.1156 |
| 9 | NALTREXONE | 2561 | 0.1114 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 57277 |
| 1 | GLP-1 Receptor Agonist [EPC] | 13138 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 12946 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9379 |
| 4 | Insulin Analog [EPC] | 8378 |
| 5 | PCSK9 Inhibitor [EPC] | 8094 |
| 6 | Corticosteroid [EPC] | 8038 |
| 7 | Interferon beta [EPC] | 6399 |
| 8 | Vitamin C [EPC] | 5727 |
| 9 | Vitamin B12 [EPC] | 5724 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-13 Antagonist [EPC] | 2 | 0.1818 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 518 | 0.1088 |
| 2 | Interferon alfa-2b [EPC] | 3 | 0.0909 |
| 3 | Cytolytic Agent [EPC] | 154 | 0.0877 |
| 4 | Melanocortin 4 Receptor Agonist [EPC] | 2 | 0.0870 |
| 5 | PCSK9 Inhibitor [EPC] | 8094 | 0.0766 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 57277 | 0.0735 |
| 7 | Recombinant Human Growth Hormone [EPC] | 832 | 0.0721 |
| 8 | GLP-1 Receptor Agonist [EPC] | 13138 | 0.0698 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 692 | 0.0647 |